Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Glenn Saldanha
|
| gptkbp:country |
gptkb:India
|
| gptkbp:focusArea |
Cardiology
Oncology Dermatology Diabetes Respiratory |
| gptkbp:foundedBy |
Gracias Saldanha
|
| gptkbp:foundedYear |
1977
|
| gptkbp:hasResearchCenter |
gptkb:India
gptkb:Switzerland gptkb:USA |
| gptkbp:headquartersLocation |
gptkb:Mumbai
|
| https://www.w3.org/2000/01/rdf-schema#label |
Glenmark
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:ISIN |
INE935A01035
|
| gptkbp:market |
Global
|
| gptkbp:numberOfEmployees |
~13,000
|
| gptkbp:products |
Active pharmaceutical ingredients
Generic drugs Specialty medicines |
| gptkbp:stockExchange |
gptkb:NSE
BSE |
| gptkbp:subsidiary |
Glenmark Life Sciences
|
| gptkbp:website |
https://www.glenmarkpharma.com/
|
| gptkbp:bfsParent |
gptkb:Hurunui_District
|
| gptkbp:bfsLayer |
7
|